La cadena de opciones muestra datos clave de las opciones de acciones de Getty Images Holdings a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Getty Images Holdings..

Getty Images Holdings (NYSE:GETY) Bolsa, Cadena de Opciones

Getty Images Holdings

Getty Images Holdings Inc is engaged in the core mission of bringing the world's creative and editorial visual content solutions to its customers to engage their audiences. the company has developed market enhancements across e-commerce, content subscriptions, user-generated content, diverse and inclusive content, and proprietary research alongside investment in its technology platform, which includes artificial intelligence and machine learning-driven search functionality and image editing and integrated APIs, to become a trusted industry leader in the visual content. Geographically the company operates in the Americas, Europe, the Middle East, Africa, and Asia-Pacific, out of which a majority of its revenue is generated from the Americas.

Medtronic, Fluor And 3 Stocks To Watch Heading Into Tuesday

Earnings

News

Pre-Market Outlook

Markets

Trading Ideas

GETY

SGMO

STNE

Aquí tienes cinco acciones estadounidenses que podrían llamar la atención de los inversores este martes: IHS, HQY, GETY, SGMO y STNE.

5 acciones en el foco este martes: IHS, HQY, GETY, SGMO y STNE

CWCO

SAIC

Aquí tienes cinco acciones estadounidenses que podrían llamar la atención de los inversores este lunes: SAIC, GETY, CTM, CWCO y TSQ.

5 acciones en el foco este lunes: SAIC, GETY, CTM, CWCO y TSQ

Getty Images Holdings, Inc. Class A Common Stock

Getty Images Holdings Inc

In the current session, Ross Stores Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROST#NASDAQ">ROST</a>) is trading at $124.32, after a 0.97% drop. Over the past month, the stock fell by 11.13%, and in the past year, by 15.90%. With performance like this, long-term shareholders are more likely to start looking into the company's price-to-earnings ratio. 

<img src="https://www.benzinga.com/files/images/story/2025/1742315418_0.png" alt="Past Year Chart" />

<h3>Evaluating Ross Stores P/E in Comparison to Its Peers</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of the 24.04 in the Specialty Retail industry, Ross Stores Inc. has a lower P/E ratio of 19.86. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1742315418_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

ROST

A Look Into Ross Stores Inc's Price Over Earnings

For many people, the idea of passive income is beyond charming, and it is what drives countless individuals to explore different <a href="https://in.benzinga.com/personal-finance/25/03/44335110/stupid-20-year-investment-plan-investor-questions-200000-dividend-strategy-is-it-stupid-to-put-in-that-much-into-schd">investment</a> approaches.
Still, one of the most common challenges investors face, especially those at the beginning of their journey, is whether to prioritize growth assets or <a href="https://in.benzinga.com/markets/25/03/44196217/53-year-old-with-200k-to-invest-seeks-best-stocks-for-retirement-should-i-go-all-in-on-etfs-or-bet-b">dividend</a> investing. Both methods have their benefits, but choosing the right course can be difficult, especially when balancing short-term financial needs with long-term <a href="https://www.benzinga.com/personal-finance/24/12/42301100/most-americans-dont-see-wealth-as-the-key-to-financial-success-heres-what-matters-more-to-59-of-them">wealth</a> expansion.
Let&#8217;s dive into the story of a 33-year-old investor with a $40,000 portfolio who is faced with this very challenge. The Reddit user has $30,000 of the total amount invested in dividend-focused assets, generating approximately $190 per month in passive income after taxes.
Don't Miss:
<ul>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
<li>Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die."<a href="https://www.benzinga.com/money/warren-buffet-make-money-when-you-sleep"> Here&#8217;s how you can earn passive income with just $100.</a></li>
</ul>
His goal is to build a portfolio that will earn him enough dividends that he can live off them and to achieve this, he plans on investing 80% to 100% of his active income into dividend shares, ETFs, and funds.
&#8220;For now, I&#8217;m thinking maybe investing up to 20% of my portfolio to &#8220;growth&#8221; like [ProShares UltraPro QQQ (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tqqq#NASDAQ">TQQQ</a>)] and [ProShares UltraPro S&amp;P 500 (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/upro#NYSE">UPRO</a>)], only on big corrections, and 80% of my portfolio continue to hold/reinvest in dividend assets. Or maybe focus only on growth, sell all dividend assets, and invest 80% now only in Index ETFs ([SPDR S&amp;P 500 ETF Trust (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/spy#NYSE">SPY</a>)], [Invesco QQQ Trust (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qqq#NASDAQ">QQQ</a>)]) and 20% in leverage ETFs&#8230; There is a psychological aspect too, when I see passive income every month–it&#8217;s very motivating to continue investing more, to grow dividend income. So, dilemma&#8230; What do you think?&#8221; the young investor wrote.
Trending: The secret weapon in billionaire investor portfolios that you almost certainly don't own yet. <a href="https://www.benzinga.com/money/masterworks">See which asset class has outpaced the S&amp;P 500 (1995-2024) – and with near-zero correlation.</a>
The Reddit community took the comments by storm, sharing advice, insights, and suggestions, so let&#8217;s dive deep into these.
<h2 class="wp-block-heading">Invest $40,000 in Growth-Focused Assets or Dividends? Reddit Responds</h2>
Prioritize Growth Assets Now, Transition to Dividends Later
Many Reddit users advised the poster to focus on growth while he&#8217;s young as this strategy typically yields higher returns over the long run.
&#8220;If you&#8217;re young, I&#8217;d stick the money in a growth fund and let it ride. If you love dividends you can drop or reinvest the dividends into growth. There&#8217;s no wrong answer&#8230; but if you&#8217;re young, you&#8217;ll end up with more money investing in &#8220;growth&#8221; now. I&#8217;m 57 and started building my dividend portfolio about 15 years ago&#8230; I live on them now,&#8221; a Redditor said.
One commenter suggested a phased approach and mentioned several funds he advised the poster to invest in.
&#8220;When younger, just try and match the market. Meaning, just buy [Vanguard S&amp;P 500 ETF (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/voo#NYSE">VOO</a>)] or [Vanguard Total Stock Market ETF (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vti#NYSE">VTI</a>)]. Averaging 10% annually, or whatever the market is doing for 30 years, is guaranteed millionaire-making based on history. If you get crazy, follow Professor G's 3-fund approach and add in [Invesco QQQ Trust (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qqq#NASDAQ">QQQ</a>)] and [Schwab U.S. Dividend Equity ETF (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/schd#NYSE">SCHD</a>)]. SCHD will be your doorway to dividends. Then, as you start nearing retirement, start pivoting more of your portfolio to high-quality income and dividend stuff. For me, that was [JPMorgan Equity Premium Income ETF (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jepi#NYSE">JEPI</a>)], [JPMorgan Nasdaq Equity Premium Income ETF (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jepq#NASDAQ">JEPQ</a>)], [iShares Preferred &amp; Income Securities ETF (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pff#NASDAQ">PFF</a>)], and about 15 other income investments and stocks,&#8221; his comment reads.
&#8220;Obviously, wealth building should be your first goal. You could use value stocks or bonds that pay dividends for diversification, but diversification doesn&#8217;t speed up wealth building, it just softens market drawdowns (and restricts bull markets),&#8221; another Redditor suggested.
A user also recommended the investor focus on growth first and later transition to dividend-paying assets.
&#8220;Focus on growth assets first, build a larger capital base, and transition into dividend investing later. In my opinion. This is my plan. Dividends are great until you have to start eating into the balance to pay large expenses,&#8221; he said.
See Also: Have $200K saved?<a href="https://www.benzinga.com/money/have-200k-saved-heres-how-to-turn-it-into-lasting-wealth"> Here's how to turn it into lasting wealth</a>
Psychological Motivation Vs. Financial Logic
Commenters also admitted the psychological benefits of dividend investing the poster mentioned, especially the motivation that comes from seeing regular income, but they also warned against letting feelings override a good financial plan.
&#8220;Many people spend their whole lives chasing an imaginary number. First, define for yourself what &#8220;enough&#8221; is and keep doing what you&#8217;re doing, you&#8217;re probably better off than you realize. Also, the &#8220;fastest&#8221; way is very rarely the most &#8220;logical&#8221; way, but the biggest thing you can do after cutting back spending is increase your income,&#8221; a commenter said.
A user cautioned against investing in too many assets and ending up having too many tickers to handle, suggesting a few ETFs instead.
&#8220;One thing I would caution against though, regardless of which way you go, is having too many tickers and positions to monitor. Once you get into individual stocks, managing more than 15-20 becomes basically a full-time job; at least to do it properly. So my personal recommendation would be to move into a few ETFs that align with your investment thesis unless you feel you can manage that many individual positions,&#8221; the Redditor advised.
Read Next:
<ul>
<li>Dogecoin millionaires are increasing –<a href="https://www.benzinga.com/money/dogecoin-millionaires"> investors with $1M+ in DOGE revealed!</a></li>
<li>How do billionaires pay less in income tax than you?<a href="https://www.benzinga.com/money/tax-deferring-adv"> Tax deferring is their number one strategy</a>.</li>
</ul>

Personal Finance

JEPI

JEPQ

iShares S&P US Preferred Stock Index Fund

SCHD

TQQQ

UPRO

Investor With $40,000 Portfolio Wonders If He Should Pick Dividend Investing Or Growth First – 'Would You Prioritize Dividends Or Growth?

<a href="https://www.fda.gov/medical-devices/medical-device-recalls/embolization-device-recall-and-correction-medtronic-removes-unused-027-compatible-pipeline-vantage#:~:text=Medical%20Device%20Recalls-,Embolization%20Device%20Recall%20and%20Correction%3A%20Medtronic%20Removes%20Unused%20027%20Compatible,Wall%20Apposition%20and%20Braid%20Deformation" title="https://www.fda.gov/medical-devices/medical-device-recalls/embolization-device-recall-and-correction-medtronic-removes-unused-027-compatible-pipeline-vantage#:~:text=Medical%20Device%20Recalls-,Embolization%20Device%20Recall%20and%20Correction%3A%20Medtronic%20Removes%20Unused%20027%20Compatible,Wall%20Apposition%20and%20Braid%20Deformation">https://www.fda.gov/medical-devices/medical-device-recalls/embolization-device-recall-and-correction-medtronic-removes-unused-027-compatible-pipeline-vantage#:~:text=Medical%20Device%20Recalls-,Embolization%20Device%20Recall%20and%20Correction%3A%20Medtronic%20Removes%20Unused%20027%20Compatible,Wall%20Apposition%20and%20Braid%20Deformation</a>

Biotech

General

FDA Says Medtronic Removes Unused 027 Compatible Pipeline Vantage Embolization Device With Shield Technology; Medtronic Updates Use Instructions For 021 Compatible Pipeline Vantage Embolization Devices; Medtronic Updates Instructions For Using Pipeline Vantage 021 Device Models Due To Risk Of Incomplete Wall Apposition & Braid Deformation

<figure class="wp-block-image size-large"><img decoding="async" src="https://thearorareport.com/wp-content/uploads/2025/03/2025-03-18_08h27_18.jpg" alt="" /></figure>
To gain an edge, this is what you need to know today.
<h4 class="wp-block-heading">Outperforming Markets</h4>
Please <a href="https://thearorareport.com/chart-analysis-stock-market-wall-street-consensus-emerging-markets-outperform-spy-mc-03182025">click here</a> for an enlarged chart comparing SPDR S&amp;P 500 ETF Trust (SPY) which represents the benchmark stock market index S&amp;P 500 (SPX), Invesco QQQ Trust Series 1 (QQQ), Euro Stoxx 50 ETF, Mexico ETF iShares MSCI Mexico ETF (EWW), and emerging markets ETF iShares MSCI Emerging Markets ETF (EEM).
Note the following:
<ul>
<li>The Arora Report's call was to buy tactical positions on President Trump's re-election and sell on the inauguration.&nbsp; That call has now proven spot on.</li>
<li>The chart shows that since Trump's inauguration, SPY is down 6.2% and QQQ is down 8.01%.</li>
<li>Wall Street's consensus call was that the U.S. stock market would go higher after Trump's inauguration.&nbsp; The chart shows that so far Wall Street's call has been wrong.</li>
<li>Another consensus call from Wall Street has also been proven wrong.&nbsp; Wall Street's call was that Nasdaq 100, which is mostly tech stocks, would outperform S&amp;P 500.&nbsp; The chart shows tech stocks have under performed S&amp;P 500 by 1.9%.</li>
<li>More striking is that, as shown on the chart,&nbsp; emerging market stocks have outperformed the U.S. stock market by 12.78%.</li>
<li>Even more remarkable, as is shown on the chart, is that large European stocks have outperformed the U.S. stock market by 17%.</li>
<li>Most remarkable is that the Mexican stock market has outperformed the U.S. stock market by 16.35%.</li>
<li>After analyzing the new administration's policies, Wall Street's consensus call was to sell emerging market stocks, including Mexican stocks, and European stocks. &nbsp; Further, Wall Street's consensus was to put the money from selling international stocks into U.S. tech stocks.&nbsp; Wall Street made two supportive arguments:
<ul>
<li>After Trump's inauguration, U.S. exceptionalism would take center stage.</li>
<li>Tariffs would hurt emerging markets, including Mexico, and Europe.</li>
</ul>
</li>
<li>Here are the three lessons from the foregoing:
<ul>
<li>A well diversified portfolio is a component of maximizing the wealth investors extract from the markets.&nbsp; Diversification should include international markets.</li>
<li>Follow Arora's Second Law of Investing and Trading that states "Nobody knows with certainty, what is going to happen next in the markets."&nbsp; Make decisions based on Arora's Third Law that states, "Making investing and trading decisions based on probabilities is the only realistic and profitable approach."&nbsp;</li>
<li>Prudent investors cannot rely solely on Wall Street consensus and media, as they are often wrong.</li>
</ul>
</li>
<li>In our analysis, Wall Street's call was wrong because Wall Street did not do a 360 degree analysis.  Wall Street was focused on only one viewpoint as it suffered from recency bias.  The recency bias was that Trump's second term would be the same as Trump's first term.  Of course, as a member of The Arora Report, you knew in advance that Trump's second term was going to be different from Trump's first term. </li>
<li>At NVIDIA Corp (NVDA) GPU Technology Conference 2025 (Nvidia GTC), the key event today is Nvidia CEO Jensen Huang's keynote speech at 1pm ET.  Huang's speech is extremely important as it will determine the direction of artificial intelligence stocks and, in turn, the entire stock market.</li>
<li>The FOMC meeting starts today.&nbsp; The rate decision will be announced tomorrow at 2pm ET followed by Chair Powell's press conference at 2:30pm ET.</li>
<li>In our analysis, the move up in the stock market over the last two days has been a result of the following:
<ul>
<li>A viscous short squeeze</li>
<li>Dip buying mentality</li>
</ul>
</li>
<li>In our analysis, this morning the first leg of the short squeeze appears to be over.  This is removing buying pressure resulting in stocks drifting lower in the early trade.</li>
</ul>
<h4 class="wp-block-heading">Housing</h4>
After a sustained period of weakness, the new data shows housing is picking up.&nbsp; Here are the details of the just released data.
<ul>
<li>Housing starts came at 1.5M vs. 1.385M consensus.</li>
<li>Building permits came at 1.456M vs. 1.450M consensus.</li>
</ul>
<h4 class="wp-block-heading">Magnificent Seven Money Flows</h4>
In the early trade, money flows are negative in NVDA, Apple Inc (AAPL), Amazon.com, Inc. (AMZN), Alphabet Inc Class C (GOOG), Meta Platforms Inc (META), Microsoft Corp (MSFT), and Tesla Inc (TSLA)
In the early trade, money flows are negative in S&amp;P 500 ETF (SPY) and Nasdaq 100 ETF (QQQ).
<h4 class="wp-block-heading">Momo Crowd And Smart Money In Stocks</h4>
Investors can gain an edge by knowing money flows in SPY and QQQ.  Investors can get a bigger edge by knowing when smart money is buying stocks, gold, and oil.  The most popular ETF for gold is SPDR Gold Trust (GLD).  The most popular ETF for silver is iShares Silver Trust (SLV).  The most popular ETF for oil is United States Oil ETF (USO).
<h4 class="wp-block-heading">Bitcoin</h4>
Bitcoin is range bound.
<h4 class="wp-block-heading">Protection Band And What To Do Now</h4>
It is important for investors to look ahead and not in the rearview mirror.  The proprietary protection band from The Arora Report puts all of the data, all of the indicators, all of the news, all of the crosscurrents, all of the models, and all of the analysis in an analytical framework that is easily actionable by investors.
Consider continuing to hold good, very long term, existing positions. Based on individual risk preference, consider a protection band consisting of cash or Treasury bills or short-term tactical trades as well as short to medium term hedges and short term hedges. This is a good way to protect yourself and participate in the upside at the same time.
You can determine your protection bands by adding cash to hedges.&nbsp; The high band of the protection is appropriate for those who are older or conservative. The low band of the protection is appropriate for those who are younger or aggressive.&nbsp; If you do not hedge, the total cash level should be more than stated above but significantly less than cash plus hedges.
A protection band of 0% would be very bullish and would indicate full investment with 0% in cash.&nbsp; A protection band of 100% would be very bearish and would indicate a need for aggressive protection with cash and hedges or aggressive short selling.
It is worth reminding that you cannot take advantage of new upcoming opportunities if you are not holding enough cash.&nbsp; When adjusting hedge levels, consider adjusting partial stop quantities for stock positions (non ETF); consider using wider stops on remaining quantities and also allowing more room for high beta stocks.&nbsp; High beta stocks are the ones that move more than the market.
<h4 class="wp-block-heading">Traditional 60/40 Portfolio</h4>
Probability based risk reward adjusted for inflation does not favor long duration strategic bond allocation at this time.
Those who want to stick to traditional 60% allocation to stocks and 40% to bonds may consider focusing on only high quality bonds and bonds of five year duration or less.&nbsp; Those willing to bring sophistication to their investing may consider using bond ETFs as tactical positions and not strategic positions at this time.
The Arora Report is known for its accurate calls. The Arora Report correctly called the big artificial intelligence rally before anyone else, the new bull market of 2023, the bear market of 2022, new stock market highs right after the virus low in 2020, the virus drop in 2020, the DJIA rally to 30,000 when it was trading at 16,000, the start of a mega bull market in 2009, and the financial crash of 2008. Please click here to sign up for a free forever <a href="https://thearorareport.com/generate-wealth-newsletter-benzinga">Generate Wealth Newsletter</a>.

Equities

Market Summary

Broad U.S. Equity ETFs

Opinion

ETFs

The Opposite Of What Wall Street Told You About Stocks Has Happened, Key Nvidia Event Ahead

The U.S. Food and Drug Administration granted on Tuesday Fast Track designation to Johnson &amp; Johnson&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>) investigational nipocalimab for moderate-to-severe <a href="https://www.benzinga.com/general/health-care" target="_blank" rel="noreferrer noopener">Sjögren&#8217;s disease (SjD)</a>.
Last year, FDA granted Breakthrough Therapy designation (BTD) for <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/n44374366/nipocalimab-the-first-and-only-investigational-treatment-to-be-granted-u-s-fda-breakthrough-therap" rel="noreferrer noopener">the investigational therapy</a>.
The Phase 2 DAHLIAS study, <a target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4384625-1&amp;h=1495278526&amp;u=https%3A%2F%2Fwww.jnj.com%2Fmedia-center%2Fpress-releases%2Fnipocalimab-demonstrates-significant-clinical-improvement-in-disease-activity-and-igg-reduction-in-phase-2-sjogrens-disease-study&amp;a=results+of+which+were+presented+last+year" rel="noreferrer noopener">presented last year</a>, represented the first-ever positive results of an investigational FcRn blocker as a potential targeted therapy in SjD.&nbsp;
<a target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4384625-1&amp;h=1819366589&amp;u=https%3A%2F%2Fwww.jnj.com%2Fmedia-center%2Fpress-releases%2Flate-breaking-results-show-nipocalimab-significantly-improves-sjogrens-disease-activity-in-a-phase-2-study&amp;a=The+study" rel="noreferrer noopener">The study</a> achieved the primary endpoint in the 15 mg/kg Q2W nipocalimab group, showing a greater than 70% relative average improvement in systemic disease activity at Week 24 compared to placebo and IgG reductions of more than 77%.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/25/03/44375773/cancer-focused-nanobiotix-adjusts-2-7-billion-johnson-johnson-agreement-to-strengthen-finances-and-relieve-funding-burden" rel="noreferrer noopener">Cancer-Focused Nanobiotix Adjusts $2.7 Billion Johnson &amp; Johnson Agreement To Strengthen Finances And Relieve Funding Burden</a>
Trends of improvement were similarly observed across multiple secondary endpoints. Safety and tolerability were consistent with other nipocalimab clinical studies.
Sjögren&#8217;s disease, also known as Sjögren&#8217;s syndrome, is&nbsp;a chronic autoimmune disorder that primarily affects the body&#8217;s exocrine glands (or moisture-producing glands), particularly those responsible for producing tears and saliva, leading to dry eyes and mouth.
Earlier this month, Johnson &amp; Johnson decided to discontinue the Phase 3 VENTURA development program evaluating aticaprant, a kappa opioid receptor (KOR) antagonist, as an adjunctive treatment for major depressive disorder (aMDD). The move follows insufficient efficacy in the target patient population. The data confirmed aticaprant is safe and well-tolerated, and no new safety <a href="https://www.benzinga.com/25/03/44190052/johnson-johnson-stops-late-stage-depression-study-over-insufficient-efficacy" target="_blank" rel="noreferrer noopener">signals were identified</a>.
In February, Sanofi SA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNY#NASDAQ">SNY</a>) and Johnson &amp; Johnson discontinued the E.mbrace phase 3 study evaluating a vaccine candidate for extraintestinal pathogenic E. coli. The companies determined that the vaccine candidate was not sufficiently effective at preventing invasive E. coli disease (IED) <a href="https://www.benzinga.com/general/biotech/25/02/43692253/sanofi-johnson-johnson-partnered-vaccine-against-bacterial-sepsis-flunks-late-stage-study" target="_blank" rel="noreferrer noopener">compared to placebo</a>.
JNJ Price Action: Johnson &amp; Johnson stock is up 0.71% at $164 at publication Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44378262/tesla-rival-zeekr-to-provide-free-advanced-driver-assistance-tech-in-china-report" target="_blank" rel="noreferrer noopener">Tesla Rival Zeekr To Provide Free Advanced Driver-Assistance Tech In China: Report</a></li>
</ul>
Photo: Gorodenkoff via Shutterstock

Large Cap

Health Care

FDA Grants Fast Track Review To Johnson & Johnson's Nipocalimab For Autoimmune Disorder That Affects Tears, Saliva

Investors with a lot of money to spend have taken a bullish stance on Reddit (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with RDDT, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 37 uncommon options trades for Reddit.
This isn't normal.
The overall sentiment of these big-money traders is split between 51% bullish and 35%, bearish.
Out of all of the special options we uncovered, 20 are puts, for a total amount of $2,831,782, and 17 are calls, for a total amount of $818,447.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $55.0 to $270.0 for Reddit over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Reddit stands at 1073.53, with a total volume reaching 10,062.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Reddit, situated within the strike price corridor from $55.0 to $270.0, throughout the last 30 days.
<h3>Reddit Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742314544_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>RDDT</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$11.85</td>
<td>$11.45</td>
<td>$11.6</td>
<td>$90.00</td>
<td>$580.0K</td>
<td>791</td>
<td>156</td>
</tr>
<tr>
<td>RDDT</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$10.6</td>
<td>$10.2</td>
<td>$10.36</td>
<td>$100.00</td>
<td>$414.4K</td>
<td>760</td>
<td>9</td>
</tr>
<tr>
<td>RDDT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$5.25</td>
<td>$5.2</td>
<td>$5.25</td>
<td>$70.00</td>
<td>$322.3K</td>
<td>1.5K</td>
<td>1.2K</td>
</tr>
<tr>
<td>RDDT</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$10.3</td>
<td>$10.2</td>
<td>$10.2</td>
<td>$110.00</td>
<td>$255.0K</td>
<td>853</td>
<td>316</td>
</tr>
<tr>
<td>RDDT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$70.25</td>
<td>$68.5</td>
<td>$69.39</td>
<td>$180.00</td>
<td>$235.9K</td>
<td>368</td>
<td>34</td>
</tr>
</tbody>
</table>

<h3>About Reddit</h3>
Reddit Inc is engaged in providing internet content. The company provides online human connections to communities, endless conversation, sports, business, crypto, television, and others. It generates a majority of revenue through the sale of advertising on mobile applications and websites. Other revenue consists of revenue from content licensing, Reddit Premium subscriptions, and products within the user economy.
Having examined the options trading patterns of Reddit, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Current Position of Reddit</h3>
<ul>
<li>With a trading volume of 6,648,803, the price of RDDT is down by -11.51%, reaching $111.11.</li>
<li>Current RSI values indicate that the stock is may be approaching oversold.</li>
<li>Next earnings report is scheduled for 68 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Reddit</h3>
Over the past month, 3 industry analysts have shared their insights on this stock, proposing an average target price of $165.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Redburn Atlantic downgraded its action to Sell with a price target of $75. 
&#x2A; Maintaining their stance, an analyst from Piper Sandler continues to hold a Overweight rating for Reddit, targeting a price of $220. 
&#x2A; An analyst from Raymond James has decided to maintain their Strong Buy rating on Reddit, which currently sits at a price target of $200. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Reddit with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Options

RDDT

Behind the Scenes of Reddit's Latest Options Trends

Financial giants have made a conspicuous bullish move on Nike. Our analysis of options history for Nike (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) revealed 22 unusual trades.
Delving into the details, we found 63% of traders were bullish, while 18% showed bearish tendencies. Out of all the trades we spotted, 7 were puts, with a value of $279,675, and 15 were calls, valued at $1,127,250.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $60.0 to $95.0 for Nike over the last 3 months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Nike's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Nike's substantial trades, within a strike price spectrum from $60.0 to $95.0 over the preceding 30 days.
<h3>Nike Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742314539_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NKE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$11.9</td>
<td>$11.45</td>
<td>$11.6</td>
<td>$75.00</td>
<td>$232.0K</td>
<td>176</td>
<td align="right">0</td>
</tr>
<tr>
<td>NKE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$11.45</td>
<td>$11.0</td>
<td>$11.3</td>
<td>$75.00</td>
<td>$226.0K</td>
<td>176</td>
<td align="right">500</td>
</tr>
<tr>
<td>NKE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$13.1</td>
<td>$11.6</td>
<td>$11.6</td>
<td>$75.00</td>
<td>$116.0K</td>
<td>176</td>
<td align="right">300</td>
</tr>
<tr>
<td>NKE</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$11.55</td>
<td>$11.4</td>
<td>$11.48</td>
<td>$62.50</td>
<td>$114.8K</td>
<td>3</td>
<td align="right">101</td>
</tr>
<tr>
<td>NKE</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$2.77</td>
<td>$2.45</td>
<td>$2.63</td>
<td>$75.00</td>
<td>$78.9K</td>
<td>14.5K</td>
<td align="right">306</td>
</tr>
</tbody>
</table>

<h3>About Nike</h3>
Nike is the largest athletic footwear and apparel brand in the world. Key categories include basketball, running, and football (soccer). Footwear generates about two thirds of its sales. Its brands include Nike, Jordan (premium athletic footwear and clothing), and Converse (casual footwear). Nike sells products worldwide through company-owned stores, franchised stores, and third-party retailers. The firm also operates e-commerce platforms in more than 40 countries. Nearly all its production is outsourced to contract manufacturers in more than 30 countries. Nike was founded in 1964 and is based in Beaverton, Oregon.
After a thorough review of the options trading surrounding Nike, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Nike's Current Market Status</h3>
<ul>
<li>With a trading volume of 3,175,372, the price of NKE is up by 0.26%, reaching $73.89.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 2 days from now.</li>
</ul>
<h3>What The Experts Say On Nike</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $85.4.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Jefferies has elevated its stance to Buy, setting a new price target at $115. 
&#x2A; Consistent in their evaluation, an analyst from Morgan Stanley keeps a Equal-Weight rating on Nike with a target price of $72. 
&#x2A; Maintaining their stance, an analyst from Telsey Advisory Group continues to hold a Market Perform rating for Nike, targeting a price of $80. 
&#x2A; An analyst from Needham persists with their Buy rating on Nike, maintaining a target price of $80. 
&#x2A; Maintaining their stance, an analyst from Telsey Advisory Group continues to hold a Market Perform rating for Nike, targeting a price of $80. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Nike options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

Unpacking the Latest Options Trading Trends in Nike

Deep-pocketed investors have adopted a bearish approach towards e.l.f. Beauty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELF#NYSE">ELF</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in ELF usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 8 extraordinary options activities for e.l.f. Beauty. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 37% leaning bullish and 62% bearish. Among these notable options, 4 are puts, totaling $369,360, and 4 are calls, amounting to $204,723.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $65.0 to $80.0 for e.l.f. Beauty over the last 3 months. 
<h3>Volume &amp; Open Interest Trends</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for e.l.f. Beauty's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of e.l.f. Beauty's whale trades within a strike price range from $65.0 to $80.0 in the last 30 days. 
<h3>e.l.f. Beauty 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742314534_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ELF</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$15.6</td>
<td>$15.55</td>
<td>$15.6</td>
<td>$70.00</td>
<td>$221.5K</td>
<td>1.0K</td>
<td align="right">193</td>
</tr>
<tr>
<td>ELF</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$15.95</td>
<td>$14.75</td>
<td>$14.75</td>
<td>$65.00</td>
<td>$88.5K</td>
<td>254</td>
<td align="right">0</td>
</tr>
<tr>
<td>ELF</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$15.6</td>
<td>$15.45</td>
<td>$15.6</td>
<td>$70.00</td>
<td>$78.0K</td>
<td>1.0K</td>
<td align="right">51</td>
</tr>
<tr>
<td>ELF</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$9.0</td>
<td>$8.9</td>
<td>$9.0</td>
<td>$75.00</td>
<td>$59.4K</td>
<td>223</td>
<td align="right">86</td>
</tr>
<tr>
<td>ELF</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$16.45</td>
<td>$16.4</td>
<td>$16.4</td>
<td>$65.00</td>
<td>$40.9K</td>
<td>271</td>
<td align="right">25</td>
</tr>
</tbody>
</table>

<h3>About e.l.f. Beauty</h3>
e.l.f. Beauty Inc is a multi-brand beauty company that offers inclusive, accessible, clean, vegan and cruelty-free cosmetics and skin care products. The Company's mission is to make the best of beauty accessible to every eye, lip, face, and skin concern. The company offers cosmetic accessories for women which include eyeliner, mascara, false eyelashes, lipstick, the foundation for the face, moisturizer, cleanser, and other tools through its stores and e-commerce channels. The products that the company sells are marketed under the e.l.f. Cosmetics, W3LL PEOPLE and Keys Soulcare brands. It carries out sales within the US and internationally, out of which maximum revenue is generated from the US.
Following our analysis of the options activities associated with e.l.f. Beauty, we pivot to a closer look at the company's own performance.
<h3>Current Position of e.l.f. Beauty</h3>
<ul>
<li>With a trading volume of 856,543, the price of ELF is down by -4.81%, reaching $62.96.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 64 days from now.</li>
</ul>
<h3>Expert Opinions on e.l.f. Beauty</h3>
In the last month, 3 experts released ratings on this stock with an average target price of $93.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from DA Davidson has decided to maintain their Neutral rating on e.l.f. Beauty, which currently sits at a price target of $80. 
&#x2A; Maintaining their stance, an analyst from DA Davidson continues to hold a Neutral rating for e.l.f. Beauty, targeting a price of $75. 
&#x2A; Maintaining their stance, an analyst from Goldman Sachs continues to hold a Buy rating for e.l.f. Beauty, targeting a price of $124. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for e.l.f. Beauty, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

e.l.f. Beauty's Options Frenzy: What You Need to Know

Hesai Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSAI#NASDAQ">HSAI</a>) stock is under pressure Tuesday after short seller Blue Orca Capital targeted the company in a new report alleging Hesai Group is actively <a href="https://www.benzinga.com/quote/HSAI">lying to investors</a>.
What To Know: Blue Orca Capital released a short report on Tuesday, calling Hesai group a &#8220;Chinese scam.&#8221; The short seller believes the company is lying by insisting it has no involvement with the Chinese military. Blue Orca also raised concerns around the company&#8217;s financial disclosures.
&#8220;In short, we think Hesai is full of lies, from its suspect financials to its denials made to the government and in court regarding its LiDAR and the Chinese military. In our opinion, it is completely untrustworthy as a business and uninvestable as a stock,&#8221; the short seller said.
Benzinga has reached out to Hesai Group for comment on the report. 
Blue Orca alleged that Hesai has lied to investors and U.S. authorities about the use of its lidar technology for military purposes. The short seller provided images that it uncovered from Chinese government owned CCTV that appears to show a Chinese military vehicle equipped with a Hesai lidar system. 
The Department of Defense (DOD) placed Hesai Group on a list of companies designated as &#8220;Chinese military companies&#8221; in January 2024. Hesai sued the DOD in an attempt to be removed from the list. The short seller believes Hesai will lose the case and in turn become effectively blocked from any lucrative deals in the U.S. autonomous vehicles market.
&#8220;As such, we believe that Hesai will soon lose a customer cohort which historically accounted for 40% of its revenues and an estimated 57% of its gross profit,&#8221; the short seller said.
Check This Out: <a href="https://www.benzinga.com/general/sports/25/03/44379231/warren-buffett-2025-march-madness-challenge-winner-no-longer-has-to-be-perfect-i-want-to-give-away-a-million-dollars">Warren Buffett 2025 March Madness Challenge Winner No Longer Has To Be Perfect: &#8216;I Want To Give Away A Million Dollars&#8217;</a>
Blue Orca also noted that Hesai Group shares surged late last year after the company reported that it became profitable. The short seller believes the profitability was a result of a $20 million break-up fee from its largest customer that was undisclosed to investors. Blue Orca also indicated that the company appears to be laying off up to 30% of its workforce. 
Hesai Group shares surged again last week after the company secured a multi-year deal with&nbsp;Mercedes-Benz&nbsp;to&nbsp;<a href="https://www.benzinga.com/pressreleases/25/03/n44237694/hesai-selected-by-top-european-oem-for-exclusive-multi-year-lidar-contract-on-its-next-generation-" target="_blank" rel="noreferrer noopener">supply lidar sensors</a>, closing the day up more than 50%. The short seller poked holes in the notion that the deal is &#8220;exclusive.&#8221; Blue Orca is also skeptical given that Mercedes was unwilling to publicly confirm the deal. The short seller noted that Hesai Group founders sold $68.6 million of stock following the spike.
Blue Orca went on to raise concerns about inconsistent purchasing volumes with reported sales, &#8220;inexplicable&#8221; margin expansion and the withdrawal of the company&#8217;s IPO in China. 
&#8220;Ultimately, we do not think that U.S. authorities will permit a Chinese military company whose products are equipped on Chinese military vehicles to take advantage of the privilege of American capital markets,&#8221; the short seller said.
HSAI Price Action: Hesai Group shares are up nearly 300% over the past year. The stock was down 8.5% at $20.39 at the time of publication Tuesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/03/44379453/equity-exposure-plummets-cash-holdings-jump-as-investors-rethink-us-exceptionalism-bank-of-america-survey">Equity Exposure Plummets, Cash Holdings Jump As Investors Rethink &#8216;US Exceptionalism,&#8217; Bank Of America Survey</a></li>
</ul>
Photo: Shutterstock.

Asia

Short Sellers

Short Ideas

HSAI

Short Seller Says Hesai Group Stock Is A 'Chinese Scam'

The Trump administration granted Nippon Steel and United States Steel Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/X#NYSE">X</a>) a 21-day extension in their lawsuit over the proposed merger, <a href="https://www.benzinga.com/25/02/43576917/trump-says-reconsiders-nippon-steels-149-billion-us-steel-deal-theyve-agreed-to-invest-heavilyas-opposed-to-own-it" target="_blank" rel="noreferrer noopener">allowing further negotiations with regulators.</a>
What Happened: The Wall Street Journal <a href="https://www.wsj.com/business/deals/nippon-steel-u-s-steel-lawsuit-gets-extension-to-continue-government-negotiations-3638d994" target="_blank" rel="noreferrer noopener">reported </a>that the Department of Justice pushed back the litigation briefing deadlines, citing a motion filed on Friday. 
Additionally, the oral argument, initially set for April 24, has been rescheduled to May 12.
The move indicates that President Donald Trump may approve the deal, <a href="https://edition.cnn.com/2025/03/17/business/us-steel-nippon-trump-cfius/index.html" target="_blank" rel="noreferrer noopener">reports </a>CNN.
Former President Joe Biden <a href="https://www.benzinga.com/trading-ideas/movers/25/01/42787508/biden-blocks-14-9b-us-steel-takeover-shares-plunge">blocked it</a>, citing national security and domestic supply chain concerns.
Also Read:<a target="_blank" href="https://www.benzinga.com/tech/25/03/44376743/google-parent-alphabet-to-acquire-wiz-in-32-billion-deal-its-biggest-bet-yet" rel="noreferrer noopener"> Google Parent Alphabet To Acquire Wiz In $32 Billion Deal, Its Biggest Bet Yet</a>
Why It Matters: Last month, Trump contemplated approving Nippon Steel&#8217;s $14.1<a href="https://www.benzinga.com/markets/asia/25/02/43574248/trump-hints-at-rekindling-nippon-steels-14-billion-acquisition-of-united-steel-in-talks-with-japanese-pm-ishiba" target="_blank" rel="noreferrer noopener"> billion bid</a> for U.S. Steel as an investment rather than a purchase. The remarks were made in the presence of Japanese Prime Minister Shigeru Ishiba at the Oval Office.
The latest extension aims to facilitate continued discussions between the companies and the government in an attempt to resolve the situation without proceeding to a full legal resolution.
In December 2023, Nippon Steel agreed to purchase U.S. Steel, but ended up in a legal dispute with the Biden administration last year over the stalled acquisition.
In early January, CEO&nbsp;Eiji Hashimoto&nbsp;<a target="_blank" href="https://www.benzinga.com/markets/25/01/42870745/nippon-steel-ceo-slams-tariffs-defends-15-billion-us-steel-merger-amid-national-security-concerns-we-never-think-that-industry-can-become-stronger-through-tariffs-alone" rel="noreferrer noopener">dismissed tariffs as an inadequate solution</a>&nbsp;for bolstering the U.S. steel industry. He defended the merger, asserting that it would strengthen national security by creating a more resilient and competitive company.
In response, Nippon Steel and U.S. Steel filed a lawsuit in January, claiming the decision was influenced by President Biden&#8217;s desire to gain favor with the United Steelworkers union in Pennsylvania.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, X stock has gained over 3% in the past year. Investors can gain exposure to the stock via&nbsp;SPDR S&amp;P Metals &amp; Mining ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XME#NYSE">XME</a>).
Price Action: X shares are trading higher by 0.36% to $40.26 premarket at last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44377660/walgreens-executive-chair-stefano-pessina-seeks-to-strengthen-control-with-nearly-double-stake" target="_blank" rel="noreferrer noopener">Walgreens&#8217; Executive Chair Stefano Pessina Seeks To Strengthen Control With Nearly Double Stake</a></li>
</ul>

Politics

Movers

Trump Eyes Approval Of Controversial Steel Merger: Nippon, US Steel Await Key Decision

Today at Adobe Summit – the flagship digital experience conference – Adobe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADBE#NASDAQ">ADBE</a>) announced a strategic collaboration with Amazon Web Services (AWS) to build new offerings that empower marketing and creative teams to deliver customer experiences with greater speed, precision and at scale. The collaboration combines Adobe's expertise in Customer Experience Orchestration with AWS's advanced cloud services.
Building on the <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fprotect.checkpoint.com%2Fv2%2F___https%3A%2Fnews.adobe.com%2Fnews%2F2024%2F12%2F120324-adobe-and-amazon-web-services-partner-to-bring-adobe-experience-platform-to-brands-and-enhance-customer-engagement-with-deep-insights___.YzJ1OndlY29tbXVuaWNhdGlvbnM6YzpvOmEyYmFiNGYyN2VmMmM3YmUzOWUyMzQ4ZTRlNzIwMGUwOjY6MDMzNjo5OTE5Y2JhYzg1ZTY4YjRjNzRlN2RiYmJmOTAzYmY4YmU5Mjg3MWQ2YjkzMzNhMTY1OWYyMmNmNDRjNzQ3YjVmOnA6RjpG&amp;esheet=54225569&amp;newsitemid=20250318724273&amp;lan=en-US&amp;anchor=availability&amp;index=1&amp;md5=922b61f87b0d114ded9ebdbef96afe8b">availability</a> of Adobe Experience Platform (AEP) on AWS, the collaboration will introduce new integrations with AWS's generative AI services, Amazon Connect and Amazon Ads. These offerings will enable organizations to create more meaningful customer interactions while benefiting from AWS's enterprise-grade security, reliability and global infrastructure.

ADBE

AMZN

Adobe And AWS Announced Strategic Collaboration To Enhance Customer Experience Orchestration With New Integrations, Including Generative AI Services, Amazon Connect, And Amazon Ads

Morgan Stanley analyst Hamza Fodderwala maintains Tenable Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TENB#NASDAQ">TENB</a>) with a Equal-Weight and lowers the price target from $47 to $40.

Price Target

Analyst Ratings

TENB

Morgan Stanley Maintains Equal-Weight on Tenable Holdings, Lowers Price Target to $40

Macro Economic Events

Contracts

Global

Economics

ORCL

Oracle Weighs Security Role, Small Stake To Land TikTok Deal; Oracle Would Offer Security Guarantee If China Keeps Algorithm

Morgan Stanley analyst Hamza Fodderwala maintains SentinelOne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/S#NYSE">S</a>) with a Equal-Weight and lowers the price target from $27 to $20.

Morgan Stanley Maintains Equal-Weight on SentinelOne, Lowers Price Target to $20

SoundHound AI, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOUN#NASDAQ">SOUN</a>) is presenting its conversational AI voice technology this week at the 2025 NVIDIA GPU Technology Conference (GTC) in <a href="https://www.benzinga.com/trading-ideas/long-ideas/25/03/44360400/legendary-trader-says-tesla-nvidia-apple-shares-are-ready-to-rally-i-see-what-i-like-to-see">San Jose, California.&nbsp;</a>
What To Know: SoundHound <a href="https://www.benzinga.com/25/03/44336786/whats-going-on-with-soundhound-ai-stock-friday">will showcase</a> several AI voice technology products, including its next-generation in-vehicle voice assistant, which integrates generative AI with NVIDIA Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)'s DRIVE AGX platform.&nbsp;
Read Next: <a href="https://www.benzinga.com/etfs/specialty-etfs/25/03/44367584/black-swan-hedge-fund-posts-4000-profits-during-covid-19-market-crash-heres-how">&#8216;Black Swan&#8217; Hedge Fund Posts 4,000% Profits During COVID-19 Market Crash: Here&#8217;s How</a>
The company will also demo its in-car voice commerce ecosystem that enables drivers to make hands-free, voice-controlled orders and purchases ordering and purchasing from their vehicle.&nbsp;
SoundHound mentioned both of the above technologies in <a href="https://x.com/SoundHound/status/1901668331125432345">a post</a> on social media and called its&nbsp; in-car voice commerce ecosystem "a game-changer for #AutomotiveTech."
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">&#x1f697;&#x1f4a1; This week, we're live from NVIDIA <a href="https://twitter.com/hashtag/GTC2025?src=hash&amp;ref_src=twsrc%5Etfw">#GTC2025</a>! Stop by booth 1842 to experience SoundHound Chat AI Automotive, our award-winning voice assistant leveraging <a href="https://twitter.com/hashtag/GenerativeAI?src=hash&amp;ref_src=twsrc%5Etfw">#GenerativeAI</a> on the edge with NVIDIA DRIVE AGX. Plus, check out our in-car voice commerce ecosystem, allowing drivers… <a href="https://t.co/OCM0xe8De4">pic.twitter.com/OCM0xe8De4</a>
&mdash; SoundHound AI (@SoundHound) <a href="https://twitter.com/SoundHound/status/1901668331125432345?ref_src=twsrc%5Etfw">March 17, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Additionally, SoundHound's AI-powered drive-thru food ordering system powered by Oracle Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) Cloud Infrastructure will be featured at Oracle's GTC booth as well.&nbsp;
SoundHound AI senior vice president Ben Bellettini recently described the company's business segments as a three-pilar design in an<a href="https://foodondemand.com/03112025/soundhound-ai-rolls-out-new-voice-features-and-bets-big-on-cars/"> interview</a> with Food On Demand.&nbsp;
"We see cars as the tip of the spear," he said, referring to SoundHound's in-vehicle voice assistant technology.&nbsp;
"Supporting automakers is a core pillar for us. A second pillar is providing voice solutions for restaurants. Our third pillar is wedding those two together."
SOUN Price Action: According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, SoundHound AI shares were down 3.27% at $9.75 amid a broad market sell-off at the time of publication Tuesday.&nbsp;
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/travel/25/03/44359238/severe-storm-system-brings-devastation-at-least-42-dead-power-outages-widespread-damage-reported">Severe Storm System Brings Devastation: At Least 42 Dead, Power Outages, Widespread Damage Reported&nbsp;</a></li>
</ul>
Photos: Shutterstock

Events

Tech

NVDA

SOUN

SoundHound AI At 2025 NVIDIA GPU Technology Conference: In-Car Voice Commerce Ecosystem 'A Game-Changer For #AutomotiveTech'

Morgan Stanley analyst Erin Wilson maintains Rapid7 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPD#NASDAQ">RPD</a>) with a Equal-Weight and lowers the price target from $38 to $33.

Morgan Stanley Maintains Equal-Weight on Rapid7, Lowers Price Target to $33

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Barclays analyst Lauren Lieberman downgraded the rating for PepsiCo, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NASDAQ">PEP</a>) from Overweight to Equal-Weight and lowered the price target from $168 to $156. PepsiCo shares closed at $151.34 on Monday. <a href="https://www.benzinga.com/quote/pep/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Guggenheim analyst Michael Schmidt downgraded Incyte Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INCY#NASDAQ">INCY</a>) from Buy to Neutral and maintained the price target of $92. Incyte shares closed at $62.01 on Monday. <a href="https://www.benzinga.com/quote/INCY/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies analyst Julien Dumoulin-Smith downgraded TPI Composites, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPIC#NASDAQ">TPIC</a>) from Hold to Underperform and lowered the price target from $2.3 to $0.5. TPI Composites shares closed at $1.20 on Monday. <a href="https://www.benzinga.com/quote/TPIC/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>UBS analyst Steven Fisher downgraded PACCAR Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCAR#NASDAQ">PCAR</a>) from Buy to Neutral and announced a $108 price target. PACCAR shares closed at $101.17 on Monday. <a href="https://www.benzinga.com/quote/PCAR/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>William Blair analyst Y Katherine Xu downgraded the rating for Incyte (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INCY#NASDAQ">INCY</a>) from Outperform to Market Perform. Incyte shares closed at $62.01 on Monday.  <a href="https://www.benzinga.com/quote/ONCY/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying PEP stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="571" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/18120202/image-151-1024x571.png" alt="" class="wp-image-829930" style="width:592px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/18120202/image-151-1024x571.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/18120202/image-151-300x167.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/18120202/image-151-768x428.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/18120202/image-151.png 1135w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/25/03/44355158/jim-cramer-says-this-tech-stock-is-a-meme-stock-recommends-buying-accenture">Jim Cramer Calls This Stock A &#8216;Meme Stock,&#8217; Recommends Buying Accenture</a></li>
</ul>

Downgrades

INCY

PCAR

TPIC

This PepsiCo Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Morgan Stanley analyst Ronald Kamdem maintains Paramount Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PGRE#NYSE">PGRE</a>) with a Equal-Weight and lowers the price target from $4.25 to $4.

PGRE

Morgan Stanley Maintains Equal-Weight on Paramount Group, Lowers Price Target to $4

Jaguar Health Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAGX#NASDAQ">JAGX</a>) shares are trading lower by 40.1% to 28 cents during Tuesday&#8217;s session after the company announced a <a href="https://www.benzinga.com/pressreleases/25/03/ac44375204/jaguar-health-inc-announces-reverse-stock-split">1-for-25 reverse stock split</a> of its common stock, set to take effect on March 24, to maintain compliance with Nasdaq listing requirements.
The stock will trade on a split-adjusted basis under the same ticker. CEO Lisa Conte stated the move aims to attract institutional investors by adjusting the share price and count. 
Approved by stockholders at a Special Meeting, the split will convert every 25 shares into one without changing par value. 
No fractional shares will be issued, and stockholders will receive cash for fractions. Equiniti Trust Company, LLC will manage the exchange, with brokerage account holders requiring no action.
Read Also: <a href="https://www.benzinga.com/trading-ideas/technicals/25/03/44378861/stock-of-the-day-does-classic-pattern-in-microsoft-mean-a-move-higher">Stock Of The Day – Does Classic Pattern In Microsoft Mean A Move Higher?</a>
<h2 class="wp-block-heading">Is JAGX A Good Stock To Buy?</h2>
An investor can make a few decisions when deciding whether a stock is a good buy. In addition to valuation metrics and price action which you can find on Benzinga's quote pages &#8211; like <a href="https://www.benzinga.com/quote/JAGX">Jaguar Health</a>&#8216;s page for example &#8211; there are factors like whether or not a company pays a dividend or buys a large portion of its stock each quarter.
Buyback programs are obviously different and highly variable. A company can approve a buyback program and purchase shares as it sees fit over the course of time in which the buyback was authorized. Looking through the latest news on <a href="https://www.benzinga.com/quote/JAGX">Jaguar Health</a> will often yield whether or not the company has approved a buyback program recently. Buyback programs usually serve as a support for share prices, serving as a backstop for demand.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, JAGX has a 52-week high of $21.60 and a 52-week low of $0.32.

JAGX

Why Jaguar Health (JAGX) Stock Is Trading Lower

RTX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>) has outperformed the market over the past 5 years by 2.68% on an annualized basis producing an average annual return of 22.92%. Currently, RTX has a market capitalization of $176.06 billion. 
Buying $1000 In RTX: If an investor had bought $1000 of RTX stock 5 years ago, it would be worth $2,548.67 today based on a price of $131.87 for RTX at the time of writing.
<h3>RTX's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742313654_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning RTX Stock In The Last 5 Years

Legal

Press Releases

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates GETY, NARI, SSY on Behalf of Shareholders

Kuehn Law Encourages VINC, NEUE, GETY, and CLBR Investors to Contact Law Firm

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates GETY, CLBR, VINC, NEUE on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TURN, DFS, GETY on Behalf of Shareholders

Getty Images and Verizon to Award $20,000 Grant to Champion Disability Representation in the Workplace

Financing

Getty Images Holdings, Inc. Announces Comprehensive Refinancing of Approximately $1.042 Billion Existing Term Loans

Getty Images to Release Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025

Sports

Getty Images and UEFA Renew Multi-Year Agreement

Getty Images Signs Multi-Year Photography Partnership with the National Women's Soccer League

Getty Images Reports Fourth Quarter and Full Year 2024 Results

CLBR

NARI

NEUE

TURN

VINC

Angi

Bumble

Cars.com

Trump Media & Technology Group Corp. - Warrants

Trump Media & Technology

EverQuote

FuboTV

Nextdoor Holdings, Inc. Class A Common Stock

Nextdoor Holdings

MediaAlpha

Hello Group Inc. - American Depositary Shares

Hello Gr

Outbrain

QuinStreet

Shutterstock

Taboola.com

Tripadvisor

TrueCar

trivago N.V. - American Depositary Shares

trivago

Travelzoo

Vimeo

Vtex

WEBTOON Entertainment Inc. - Common stock

Webtoon Entertainment

Yalla Group Limited American Depositary Shares, each representing one Class A Ordinary Share

Yalla Group

Yelp

Ziff Davis

Zhihu Inc. American Depositary Shares, each representing three (3) Class A Ordinary Shares

Comments

Getty Images Holdings

Getty Images Holdings (GETY) Opciones

Getty Images Holdings (NYSE:GETY) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL